130 results on '"Capanni C"'
Search Results
2. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment
- Author
-
Columbaro, M., Capanni, C., Mattioli, E., Novelli, G., Parnaik, V. K., Squarzoni, S., Maraldi, N. M., and Lattanzi, G.
- Published
- 2005
- Full Text
- View/download PDF
3. Investigation of the effects of copper ions on protein aggregation using a model system
- Author
-
Capanni, C., Taddei, N., Gabrielli, S., Messori, L., Orioli, P., Chiti, F., Stefani, M., and Ramponi, G.
- Published
- 2004
- Full Text
- View/download PDF
4. Emerin presence in platelets
- Author
-
Squarzoni, S., Sabatelli, P., Capanni, C., Petrini, S., Ognibene, A., Toniolo, D., Cobianchi, F., Zauli, G., Bassini, A., Baracca, A., Guarnieri, C., Merlini, L., and Maraldi, N. M.
- Published
- 2000
- Full Text
- View/download PDF
5. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery–Dreifuss muscular dystrophy
- Author
-
Cenni, V, Sabatelli, P, Mattioli, E, Marmiroli, S, Capanni, C, Ognibene, A, Squarzoni, S, Maraldi, N M, Bonne, G, Columbaro, M, Merlini, L, and Lattanzi, G
- Published
- 2005
6. Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene
- Author
-
Merlini, L, Carbone, I, Capanni, C, Sabatelli, P, Tortorelli, S, Sotgia, F, Lisanti, M P, Bruno, C, and Minetti, C
- Published
- 2002
7. Histopathological assessment of disease target organs in a mouse model of progeria (LMNA G609G/G609G)
- Author
-
SARLI G., SQUARZONI S., PELLEGRINO V., AVALLONE G., ZAGHINI A., BARBONI C., LOI M., SCHENA E., CAPANNI C., LATTANZI G., Comitato Scientifico SISVET/AIPVET, Comitato Scientifico SISVET, and SARLI G., SQUARZONI S., PELLEGRINO V., AVALLONE G., ZAGHINI A., BARBONI C., LOI M., SCHENA E., CAPANNI C., LATTANZI G.
- Subjects
progeria, mouse model, target organs - Published
- 2017
8. Slug transcription factor and nuclear Lamin B1 are upregulated in osteoarthritic chondrocytes
- Author
-
Piva, R., Lambertini, E., Manferdini, C., Capanni, C., Penolazzi, L., Gabusi, E., Paolella, F., Lolli, A., Angelozzi, M., Lattanzi, G., and Lisignoli, G.
- Published
- 2015
- Full Text
- View/download PDF
9. Inhibition of metalloproteinase activity in FANCA is linked to altered oxygen metabolism
- Author
-
Ravera S, Capanni C, Tognotti D, Bottega R, Columbaro M, Dufour C, Cappelli E, and Degan P.
- Subjects
COMPLEX I DEFECTS ,DNA Repair ,MATRIX METALLOPROTEINASES ,Muscle Proteins ,RESTRICTIVE DERMOPATHY ,Antioxidants ,DNA-Binding Proteins ,Mitochondrial Proteins ,Oxygen ,Fanconi Anemia ,Bone Marrow ,Chromosomal Instability ,Metalloproteases ,Humans ,Vimentin ,Female ,COMPLEMENTATION GROUP-A ,Muscle, Skeletal - Abstract
Bone marrow (BM) failure, increased risk of myelodysplastic syndrome, acute leukaemia and solid tumors, endocrinopathies and congenital abnormalities are the major clinical problems in Fanconi Anemia patients (FA). Chromosome instability and DNA repair defects are the cellular characteristics used for the clinical diagnosis. However, these biological defects are not sufficient to explain all the clinical phenotype of FA patie nts. The known defects are structural alteration in cell cytoskeleton , altered structural organization for intermediate filaments, nuclear lamina and mitochondria. These are associated with different expression and/or maturation of the structural proteins vimentin, mitofilin and lamin A/C. suggesting the involvement of metalloproteinases (MPs). Matrix metalloproteinases (MMP) are involved in normal physiological processes such as human skeletal tissue development, maturation and hematopoietic reconstitution after bone marrow suppression. Current observations upon the eventual role of MPs in FA cells are largely inconclusive. We evaluated the overall MPs activity in FA complementation group A (FANCA) cells by exposing them to the antioxidants N-acetyl cysteine (NAC) and resveratrol (RV). This work supports the hypothesis that treatment of Fanconi patients with antioxidants may be important in FA therapy. J. Cell. Physiol. © 2014 Wiley Periodicals, Inc.
- Published
- 2015
10. Lamin B partecipates in cartilage senescence and degeneration
- Author
-
Lambertini, Elisabetta, Manferdini, C., Capanni, C., Penolazzi, Maria Letizia, Lolli, A., Di Ciano, M., Lattanzi, G., Lisignoli, G., and Piva, Maria Roberta
- Subjects
Socio-culturale - Published
- 2014
11. Changes in vimentin , lamin A/C and mitofilin induces aberrant organelles in fibroblasts from Fanconi anemia complementation group A (FA-A) patients
- Author
-
Capanni, C., Bruschi, M., Columbaro, M., Cuccarolo, Paola, Ravera, Silvia, Dufour, Carlo, Candiano, G., Petretto, A., Degan, P., and Cappelli, E.
- Published
- 2013
12. Dysferlin in a hyperCKaemic patient with caveolin-3 mutation and in C2C12 cells after p38 MAP kinase inibition
- Author
-
Capanni, C, Sabatelli, P, Mattioli, E, Ognibene, A, Columbaro, M, Lattanzi, G, Merlini, L, Minetti, Carlo, Maraldi, Nm, and Squarzoni, S.
- Published
- 2003
13. Protein Aggregation and Amyloid Fibrils Formation Probed by Limited Proteolysis
- Author
-
POLVERINO DE LAURETO, Patrizia, Taddei, N., Frare, Erica, Chiti, F., Capanni, C., and Fontana, S. COSTANTINI AND A.
- Published
- 2002
14. Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria.
- Author
-
Cenni, V., Capanni, C., Columbaro, M., Ortolani, M., D'Apice, M.R., Novelli, G., Fini, M., Marmiroli, S., Scarano, E., Maraldi, N. M., Squarzoni, S., Prencipe, S., and Lattanzi, G.
- Published
- 2011
- Full Text
- View/download PDF
15. Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle.
- Author
-
Mattioli, E., Columbaro, M., Capanni, C., Maraldi, N. M., Cenni, V., Scotlandi, K., Marino, M. T., Merlini, L., Squarzoni, S., and Lattanzi, G.
- Subjects
NUCLEAR membranes ,GENETIC mutation ,MUSCULAR dystrophy ,CARDIOMYOPATHIES ,MYOBLASTS - Abstract
Lamin A is a nuclear lamina constituent expressed in differentiated cells. Mutations in the LMNA gene cause several diseases, including muscular dystrophy and cardiomyopathy. Among the nuclear envelope partners of lamin A are Sad1 and UNC84 domain-containing protein 1 (SUN1) and Sad1 and UNC84 domain-containing protein 2 (SUN2), which mediate nucleo-cytoskeleton interactions critical to the anchorage of nuclei. In this study, we show that differentiating human myoblasts accumulate farnesylated prelamin A, which elicits upregulation and recruitment of SUN1 to the nuclear envelope and favors SUN2 enrichment at the nuclear poles. Indeed, impairment of prelamin A farnesylation alters SUN1 recruitment and SUN2 localization. Moreover, nuclear positioning in myotubes is severely affected in the absence of farnesylated prelamin A. Importantly, reduced prelamin A and SUN1 levels are observed in Emery-Dreifuss muscular dystrophy (EDMD) myoblasts, concomitant with altered myonuclear positioning. These results demonstrate that the interplay between SUN1 and farnesylated prelamin A contributes to nuclear positioning in human myofibers and may be implicated in pathogenetic mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
16. Announcement of the Editor-in-Chief.
- Author
-
Columbaro, M., Capanni, C., Mattioli, E., Novelli, G., Parnaik, V. K., Squarzoni, S., Maraldi, N. M., Lattanzi, G., Mayer, M. P., and Bukau, B.
- Subjects
- *
CYTOLOGICAL research , *PROGERIA , *NANOPARTICLES , *G proteins , *MOLECULAR chaperones - Abstract
As decided in July 2005 we continue to publish once a year (in July) the names of the authors and the titles of the two most read (by Internet) Research Papers and Reviews published in Cell. Mol. Life Sci. the previous year. Thus we have the pleasure to provide you with the results of 2005. M. Columbaro a, C. Capanni b, E. Mattioli a, G. Novelli c, V. K. Parnaik d, S. Squarzoni b, N. M. Maraldi a, b and G. Lattanzi b E. Garcia-Garcia a, S. Gil b, K. Andrieux a, D. Desmaële c, V. Nicolas d, F. Taran e, D. Georgin e, J. P. Andreux b, F. Roux f and P. Couvreur a C. R. McCudden, M. D. Hains, R. J. Kimple, D. P. Siderovski and F. S. Willard M. P. Mayer and B. Bukau [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
17. Work ability index in a cohort of railway construction workers
- Author
-
Capanni, C., Sartori, S., Carpentiero, G., and Costa, G.
- Subjects
- *
CONSTRUCTION workers , *RAILROADS , *WORK environment , *AGE groups - Abstract
Abstract: Working conditions and work load can have a significant effect on work ability, due not only to their direct impact on health and well-being, but also to the possibility they let to maintain job and competence at acceptable levels with normal ageing. In this perspective a cohort of 377 manual workers, aged between 21 and 67 years, engaged in a railway tunnel digging have been examined. They were miners, carpenters, maintenance workers, dumper drivers and clerks/storekeepers. In the whole cohort, the Work Ability Index resulted excellent in 23.6%, good in 47.2%, moderate in 24.4%, and poor in 4.8% of the workers (12.2% in those over 55 years). The mean WAI progressively decreases from the youngest to the oldest decade (from 41.5 in subjects under 25 years to 36.0 in subjects over 55 years), and passing from day-work (39.7) to semi-continuous three-shift work (39.2) and continuous 3-shift work (37.7). Miners and carpenters showed the highest percentages of poor-moderate WAI (31.6% and 35.1% respectively); these latter show also a steeper decrement over the years. Compared to other working groups of industrial and service sectors, the railway construction workers show the lower mean WAI scores at all age groups and the most pronounced decrease over decades. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
18. Nuclear alterations in autosomal-dominant Emery-Dreifuss muscular dystrophy.
- Author
-
Sabatelli, Patrizia, Lattanzi, Giovanna, Ognibene, Andrea, Columbaro, Marta, Capanni, Cristina, Merlini, Luciano, Maraldi, Nadir M., Squarzoni, Stefano, Sabatelli, P, Lattanzi, G, Ognibene, A, Columbaro, M, Capanni, C, Merlini, L, Maraldi, N M, and Squarzoni, S
- Published
- 2001
- Full Text
- View/download PDF
19. Emerin expression at the early stages of myogenic differentiation.
- Author
-
Lattanzi, G., Ognibene, A., Sabatelli, P., Capanni, C., Columbaro, M., Santi, S., Riccio, M., Merlini, L., Maraldi, N.M., Squarzoni, S., and Toniolo, D.
- Subjects
MYOBLASTS ,CELL differentiation ,MYOGENESIS - Abstract
Abstract Emerin is an ubiquitous protein localized at the nuclear membrane of most cell types including muscle cells. The protein is absent in most patients affected by the X-linked form of Emery-Dreifuss muscular dystrophy, a disease characterized by slowly progressive muscle wasting and weakness, early contractures of the elbows, Achilles tendons, and post-cervical muscles, and cardiomyopathy. Besides the nuclear localization, emerin cytoplasmic distribution has been suggested in several cell types. We studied the expression and the subcellular distribution of emerin in mouse cultured C2C12 myoblasts and in primary cultures of human myoblasts induced to differentiate or spontaneously differentiating in the culture medium. In differentiating myoblasts transiently transfected with a cDNA encoding the complete emerin sequence, the protein localized at the nuclear rim of all transfected cells and also in the cytoplasm of some myoblasts and myotubes. Cytoplasmic emerin was also observed in detergent-treated myotubes, as determined by electron microscopy observation. Both immunofluorescence and biochemical analysis showed, that upon differentiation of C2C12 cells, emerin expression was decreased in the resting myoblasts but the protein was highly represented in the developing myotubes at the early stage of cell fusion. Labeling with specific markers of myogenesis such as troponin-T and myogenin permitted the correlation of increased emerin expression with the onset of muscle differentiation. These data suggest a role for emerin during proliferation of activated satellite cells and at the early stages of differentiation. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
20. The empowerment of translational research: lessons from laminopathies
- Author
-
Benedetti Sara, Bernasconi Pia, Bertini Enrico, Biagini Elena, Boriani Giuseppe, Capanni Cristina, Carboni Nicola, Cenacchi Giovanna, Columbaro Marta, D'Adamo Monica, D’Amico Adele, D’Apice Maria, Fontana Marianna, Gambineri Alessandra, Lattanzi Giovanna, Liguori Rocco, Maraldi Nadir M, Mazzanti Laura, Mercuri Eugenio, Mongini Tiziana, Morandi Lucia O, Neri Iria, Nigro Giovanni, Novelli Giuseppe, Ortolani Michela, Pasquali Renato, Pini Antonella, Petrini Stefania, Politano Luisa, Previtali Stefano, Pucci Lisa, Rapezzi Claudio, Ricci Giulia, Rodolico Carmelo, Sbraccia Paolo, Scarano Emanuela, Siciliano Gabriele, Squarzoni Stefano, Toscano Antonio, Vercelli Liliana, and Ziacchi Matteo
- Subjects
Laminopathies ,Emery-Dreifuss Muscular Dystrophy ,Dilated Cardiomyopathy with Conduction Defects ,Mandibuloacral Dysplasia ,Familial Partial Lipodystrophy Type 2 ,Hutchinson-Gilford Progeria Syndrome ,Rare Diseases ,Networking activity ,interdisciplinary approach to diseases ,Medicine - Abstract
Abstract The need for a collaborative approach to complex inherited diseases collectively referred to as laminopathies, encouraged Italian researchers, geneticists, physicians and patients to join in the Italian Network for Laminopathies, in 2009. Here, we highlight the advantages and added value of such a multidisciplinary effort to understand pathogenesis, clinical aspects and try to find a cure for Emery-Dreifuss muscular dystrophy, Mandibuloacral dysplasia, Hutchinson-Gilford Progeria and forms of lamin-linked cardiomyopathy, neuropathy and lipodystrophy.
- Published
- 2012
- Full Text
- View/download PDF
21. G.P.5.09 Pre-lamin A is modulated during muscle cell differentiation. Implications for Emery–Dreifuss muscular dystrophy
- Author
-
Capanni, C., Squarzoni, S., Mattioli, E., Cenni, V., Columbaro, M., Maraldi, N., Merlini, L., and Lattanzi, G.
- Published
- 2007
- Full Text
- View/download PDF
22. Simultaneous detection of reduced and oxidized glutathione in tissues and mitochondria by capillary electrophoresis
- Author
-
Muscari, C, Pappagallo, M, Ferrari, D, Giordano, E, Capanni, C, Caldarera, C.M, and Guarnieri, C
- Published
- 1998
- Full Text
- View/download PDF
23. Interleukin-6 neutralization ameliorates symptoms in prematurely aged mice
- Author
-
Giovanna Lattanzi, Elisa Schena, Giuseppe Sarli, Gianluca Storci, Elisabetta Mattioli, Davide Andrenacci, Anna Zaghini, Massimiliano Bonafè, Patrizia Sabatelli, Catia Barboni, Valeria Pellegrino, Vittoria Cenni, Cristina Capanni, Maria Rosaria D'Apice, Stefano Squarzoni, Mara Sanapo, Fabio Baruffaldi, Anna Festa, Squarzoni S., Schena E., Sabatelli P., Mattioli E., Capanni C., Cenni V., D'Apice M.R., Andrenacci D., Sarli G., Pellegrino V., Festa A., Baruffaldi F., Storci G., Bonafe M., Barboni C., Sanapo M., Zaghini A., and Lattanzi G.
- Subjects
0301 basic medicine ,Premature aging ,anti‐aging ,Aging ,medicine.medical_specialty ,congenital, hereditary, and neonatal diseases and abnormalities ,Adipose tissue ,Inflammation ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,Progeria ,0302 clinical medicine ,Tocilizumab ,Internal medicine ,medicine ,cytokine ,Animals ,Humans ,accelerated aging ,cellular senescence ,Interleukin 6 ,laminopathie ,biology ,integumentary system ,Interleukin-6 ,laminopathies ,anti-aging ,nutritional and metabolic diseases ,Original Articles ,Cell Biology ,medicine.disease ,Progerin ,cytokines ,3. Good health ,030104 developmental biology ,Endocrinology ,chemistry ,ageing ,inflammation ,biology.protein ,Original Article ,medicine.symptom ,Lipodystrophy ,030217 neurology & neurosurgery ,nuclear lamina - Abstract
Hutchinson–Gilford progeria syndrome (HGPS) causes premature aging in children, with adipose tissue, skin and bone deterioration, and cardiovascular impairment. In HGPS cells and mouse models, high levels of interleukin‐6, an inflammatory cytokine linked to aging processes, have been detected. Here, we show that inhibition of interleukin‐6 activity by tocilizumab, a neutralizing antibody raised against interleukin‐6 receptors, counteracts progeroid features in both HGPS fibroblasts and LmnaG609G / G609G progeroid mice. Tocilizumab treatment limits the accumulation of progerin, the toxic protein produced in HGPS cells, rescues nuclear envelope and chromatin abnormalities, and attenuates the hyperactivated DNA damage response. In vivo administration of tocilizumab reduces aortic lesions and adipose tissue dystrophy, delays the onset of lipodystrophy and kyphosis, avoids motor impairment, and preserves a good quality of life in progeroid mice. This work identifies tocilizumab as a valuable tool in HGPS therapy and, speculatively, in the treatment of a variety of aging‐related disorders., Signs of premature ageing are improved by tocilizumab treatment. A study in a murine model of Hutchinson‐Gilford Progeria shows that neutralization of interleukin 6 preserves motor activity and slows‐down tissue deterioration.
- Published
- 2021
24. Morphological study of TNPO3 and SRSF1 interaction during myogenesis by combining confocal, structured illumination and electron microscopy analysis
- Author
-
Cristina Capanni, Nicoletta Zini, Roberta Costa, Corrado Angelini, Giovanna Lattanzi, Roberta Marozzo, Giovanna Cenacchi, Maria Teresa Rodia, Spartaco Santi, Valentina Pegoraro, Costa R., Rodia M.T., Zini N., Pegoraro V., Marozzo R., Capanni C., Angelini C., Lattanzi G., Santi S., and Cenacchi G.
- Subjects
0301 basic medicine ,Cytoplasm ,TNPO3 ,Cellular differentiation ,Confocal ,Clinical Biochemistry ,Muscle disorder ,Muscle Development ,Article ,Cell Line ,Mice ,03 medical and health sciences ,0302 clinical medicine ,SR protein ,Electron microscopy ,Animals ,Molecular Biology ,Cell Nucleus ,Structured illumination microscopy ,Microscopy, Confocal ,Serine-Arginine Splicing Factors ,Myogenesis ,Chemistry ,Alternative splicing ,Cell Biology ,General Medicine ,beta Karyopherins ,Cell biology ,SRSF1 ,Microscopy, Electron ,030104 developmental biology ,Myogenesi ,RNA splicing ,030217 neurology & neurosurgery - Abstract
Transportin3 (TNPO3) shuttles the SR proteins from the cytoplasm to the nucleus. The SR family includes essential splicing factors, such as SRSF1, that influence alternative splicing, controlling protein diversity in muscle and satellite cell differentiation. Given the importance of alternative splicing in the myogenic process and in the maintenance of healthy muscle, alterations in the splicing mechanism might contribute to the development of muscle disorders. Combining confocal, structured illumination and electron microscopy, we investigated the expression of TNPO3 and SRSF1 during myogenesis, looking at nuclear and cytoplasmic compartments. We investigated TNPO3 and its interaction with SRSF1 and we observed that SRSF1 remained mainly localized in the nucleus, while TNPO3 decreased in the cytoplasm and was strongly clustered in the nuclei of differentiated myotubes. In conclusion, combining different imaging techniques led us to describe the behavior of TNPO3 and SRSF1 during myogenesis, showing that their dynamics follow the myogenic process and could influence the proteomic network necessary during myogenesis. The combination of different high-, super- and ultra-resolution imaging techniques led us to describe the behavior of TNPO3 and its interaction with SRSF1, looking at nuclear and cytoplasmic compartments. These observations represent a first step in understanding the role of TNPO3 and SRFSF1 in complex mechanisms, such as myogenesis.
- Published
- 2021
25. Altered chromatin organization and SUN2 localization in mandibuloacral dysplasia are rescued by drug treatment
- Author
-
Giuseppe Novelli, Elisa Schena, Cristina Capanni, Marta Columbaro, Michela Ortolani, Maria Rosaria D'Apice, Nadir M. Maraldi, Vittoria Cenni, Giovanna Lattanzi, Stefano Squarzoni, Daria Camozzi, Camozzi D, D'Apice MR, Schena E, Cenni V, Columbaro M, Capanni C, Maraldi NM, Squarzoni S, Ortolani M, Novelli G, and Lattanzi G.
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Histology ,Lipodystrophy ,Nuclear Envelope ,Blotting, Western ,Fluorescent Antibody Technique ,Laminopathy ,Mandible ,Biology ,LMNA ,HETEROCHROMATIN DEFECTS ,PRELAMIN A FORMS ,medicine ,Humans ,STATINS ,Lovastatin ,Protein Precursors ,Nuclear protein ,Molecular Biology ,Cells, Cultured ,Skin ,Original Paper ,Acro-Osteolysis ,integumentary system ,Intracellular Signaling Peptides and Proteins ,Membrane Proteins ,Nuclear Proteins ,Cell Biology ,Fibroblasts ,Chromatin Assembly and Disassembly ,Lamin Type A ,medicine.disease ,Molecular biology ,Chromatin ,Mandibuloacral dysplasia ,Medical Laboratory Technology ,MANDIBULOACRAL DYSPLASIA TYPE A (MADA) ,Trichostatin A ,Membrane protein ,SUN2 ,Hydroxymethylglutaryl-CoA Reductase Inhibitors ,Protein Processing, Post-Translational ,Lamin ,medicine.drug - Abstract
Mandibuloacral dysplasia type A (MADA) is a rare laminopathy characterized by growth retardation, craniofacial anomalies, bone resorption at specific sites including clavicles, phalanges and mandibula, mottled cutaneous pigmentation, skin rigidity, partial lipodystrophy, and insulin resistance. The disorder is caused by recessive mutations of the LMNA gene encoding for A-type lamins. The molecular feature of MADA consists in the accumulation of the unprocessed lamin A precursor, which is detected at the nuclear rim and in intranuclear aggregates. Here, we report the characterization of prelamin A post-translational modifications in MADA cells that induce alterations in the chromatin arrangement and dislocation of nuclear envelope-associated proteins involved in correct nucleo-cytoskeleton relationships. We show that protein post-translational modifications change depending on the passage number, suggesting the onset of a feedback mechanism. Moreover, we show that treatment of MADA cells with the farnesyltransferase inhibitors is effective in the recovery of the chromatin phenotype, altered in MADA, provided that the cells are at low passage number, while at high passage number, the treatment results ineffective. Moreover, the distribution of the lamin A interaction partner SUN2, a constituent of the nuclear envelope, is altered by MADA mutations, as argued by the formation of a highly disorganized lattice. Treatment with statins partially rescues proper SUN2 organization, indicating that its alteration is caused by farnesylated prelamin A accumulation. Given the major role of SUN1 and SUN2 in the nucleo-cytoskeleton interactions and in regulation of nuclear positioning in differentiating cells, we hypothesise that mechanisms regulating nuclear membrane–centrosome interplay and nuclear movement may be affected in MADA fibroblasts. Electronic supplementary material The online version of this article (doi:10.1007/s00418-012-0977-5) contains supplementary material, which is available to authorized users.
- Published
- 2012
26. Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria
- Author
-
Stefano Squarzoni, Michela Ortolani, Giovanna Lattanzi, N.M. Maraldi, Cristina Capanni, Sandra Marmiroli, Maria Rosaria D'Apice, Giuseppe Novelli, Vittoria Cenni, Sabino Prencipe, Emanuela Scarano, Milena Fini, Marta Columbaro, Cenni V, Capanni C, Columbaro M, Ortolani M, D'Apice MR, Novelli G, Fini M, Marmiroli S, Scarano E, Maraldi NM, Squarzoni S, Prencipe S, and Lattanzi G
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Histology ,PROTEIN DEGRADATION ,Nuclear Envelope ,Blotting, Western ,LAMINOPATHIES ,Biophysics ,PRELAMIN A ,Biology ,Protein degradation ,prelamin A, autophagy, protein degradation, laminopathies, progeria, Rapamycinprelamin A, autophagy, protein degradation, laminopathies, progeria, Rapamycin ,PROGERIA ,Prenylation ,Histone methylation ,medicine ,Humans ,Protein Precursors ,Nuclear protein ,Child ,Rapamycin ,lcsh:QH301-705.5 ,Cells, Cultured ,Sirolimus ,Original Paper ,Progeria ,integumentary system ,Nuclear Proteins ,nutritional and metabolic diseases ,Cell Biology ,Fibroblasts ,Lamin Type A ,Progerin ,medicine.disease ,Chromatin ,Anti-Bacterial Agents ,Cell biology ,Biochemistry ,lcsh:Biology (General) ,AUTOPHAGY ,prelamin A ,progeria ,autophagy ,RAPAMYCIN ,Lamin - Abstract
Farnesylated prelamin A is a processing intermediate produced in the lamin A maturation pathway. Accumulation of a truncated farnesylated prelamin A form, called progerin, is a hallmark of the severe premature ageing syndrome, Hutchinson-Gilford progeria. Progerin elicits toxic effects in cells, leading to chromatin damage and cellular senescence and ultimately causes skin and endothelial defects, bone resorption, lipodystrophy and accelerated ageing. Knowledge of the mechanism underlying prelamin A turnover is critical for the development of clinically effective protein inhibitors that can avoid accumulation to toxic levels without impairing lamin A/C expression, which is essential for normal biological functions. Little is known about specific molecules that may target farnesylated prelamin A to elicit protein degradation. Here, we report the discovery of rapamycin as a novel inhibitor of progerin, which dramatically and selectively decreases protein levels through a mechanism involving autophagic degradation. Rapamycin treatment of progeria cells lowers progerin, as well as wild-type prelamin A levels, and rescues the chromatin phenotype of cultured fibroblasts, including histone methylation status and BAF and LAP2alpha distribution patterns. Importantly, rapamycin treatment does not affect lamin C protein levels, but increases the relative expression of the prelamin A endoprotease ZMPSTE24. Thus, rapamycin, an antibiotic belonging to the class of macrolides, previously found to increase longevity in mouse models, can serve as a therapeutic tool, to eliminate progerin, avoid farnesylated prelamin A accumulation, and restore chromatin dynamics in progeroid laminopathies.
- Published
- 2011
27. Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle
- Author
-
Maria Teresa Marino, Luciano Merlini, Elisabetta Mattioli, Giovanna Lattanzi, Marta Columbaro, Nadir M. Maraldi, Cristina Capanni, Katia Scotlandi, Vittoria Cenni, Stefano Squarzoni, Mattioli E, Columbaro M, Capanni C, Maraldi NM, Cenni V, Scotlandi K, Marino MT, Merlini L, Squarzoni S, and Lattanzi G.
- Subjects
muscular dystrophy ,congenital, hereditary, and neonatal diseases and abnormalities ,Nuclear Envelope ,Cellular differentiation ,nuclear positioning ,Muscle Fibers, Skeletal ,Biology ,Myoblasts ,LMNA ,medicine ,Humans ,Lovastatin ,Protein Precursors ,Muscular dystrophy ,Nuclear protein ,Muscle, Skeletal ,Molecular Biology ,Cells, Cultured ,Cell Nucleus ,Prenylation ,Original Paper ,prelamin A ,integumentary system ,Myogenesis ,Anticholesteremic Agents ,Stem Cells ,MUSCLE DIFFERENTIATION ,Intracellular Signaling Peptides and Proteins ,Membrane Proteins ,Nuclear Proteins ,Cell Differentiation ,Cell Biology ,Lamin Type A ,medicine.disease ,Muscular Dystrophy, Emery-Dreifuss ,Cell biology ,Cell nucleus ,HEK293 Cells ,medicine.anatomical_structure ,Biochemistry ,SUN1 ,Nuclear lamina ,Microtubule-Associated Proteins ,Lamin - Abstract
Lamin A is a nuclear lamina constituent expressed in differentiated cells. Mutations in the LMNA gene cause several diseases, including muscular dystrophy and cardiomyopathy. Among the nuclear envelope partners of lamin A are Sad1 and UNC84 domain-containing protein 1 (SUN1) and Sad1 and UNC84 domain-containing protein 2 (SUN2), which mediate nucleo-cytoskeleton interactions critical to the anchorage of nuclei. In this study, we show that differentiating human myoblasts accumulate farnesylated prelamin A, which elicits upregulation and recruitment of SUN1 to the nuclear envelope and favors SUN2 enrichment at the nuclear poles. Indeed, impairment of prelamin A farnesylation alters SUN1 recruitment and SUN2 localization. Moreover, nuclear positioning in myotubes is severely affected in the absence of farnesylated prelamin A. Importantly, reduced prelamin A and SUN1 levels are observed in Emery-Dreifuss muscular dystrophy (EDMD) myoblasts, concomitant with altered myonuclear positioning. These results demonstrate that the interplay between SUN1 and farnesylated prelamin A contributes to nuclear positioning in human myofibers and may be implicated in pathogenetic mechanisms.
- Published
- 2011
28. Lamin A precursor induces barrier-to-autointegration factor nuclear localization
- Author
-
Tokuko Haraguchi, Cristina Capanni, Egon Ogris, Vittoria Cenni, Giovanna Lattanzi, Nadir M. Maraldi, Giuseppe Novelli, Stefano Squarzoni, Stefan Schüchner, Capanni C, Cenni V, Haraguchi T, Squarzoni S, Schüchner S, Ogris E, Novelli G, Maraldi NM, and Lattanzi G.
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Barrier-to-autointegration factor ,Biology ,Chromatin remodeling ,Progeria ,medicine ,Animals ,Humans ,Protein Precursors ,Nuclear protein ,Molecular Biology ,Cell Nucleus ,Genetics ,integumentary system ,Nuclear Proteins ,nutritional and metabolic diseases ,Cell Biology ,Fibroblasts ,Lamin Type A ,Progerin ,medicine.disease ,Rats ,Chromatin ,Cell biology ,DNA-Binding Proteins ,Protein Transport ,HEK293 Cells ,Settore MED/03 - Genetica Medica ,Nuclear lamina ,Protein Processing, Post-Translational ,Lamin ,Protein Binding ,Developmental Biology - Abstract
Lamin A, a protein component of the nuclear lamina, is synthesized as a precursor named prelamin A, whose multi-step maturation process involves different protein intermediates. As demonstrated in laminopathies such as familial partial lipodystrophy, mandibuloacral dysplasia, Werner syndrome, Hutchinson-Gilford progeria syndrome and restrictive dermopathy, failure of prelamin A processing results in the accumulation of lamin A protein precursors inside the nucleus which dominantly produces aberrant chromatin structure. To understand if nuclear lamina components may be involved in prelamin A chromatin remodeling effects, we investigated barrier-to-autointegration factor (BAF) localization and expression in prelamin A accumulating cells. BAF is a DNA-binding protein that interacts directly with histones, lamins and LEM-domain proteins and has roles in chromatin structure, mitosis and gene regulation. In this study, we show that the BAF heterogeneous localization between nucleus and cytoplasm observed in HEK293 cycling cells changes in response to prelamin A accumulation. In particular, we observed that the accumulation of lamin A, non-farnesylated prelamin A and farnesylated carboxymethylated lamin A precursors induce BAF nuclear translocation. Moreover, we show that the treatment of human fibroblasts with prelamin A interfering drugs results in similar changes. Finally, we report that the accumulation of progerin, a truncated form of farnesylated and carboxymethylated prelamin A identified in Hutchinson-Gilford progeria syndrome cells, induces BAF recruitment in the nucleus. These findings are supported by coimmunoprecipitation of prelamin A or progerin with BAF in vivo and suggest that BAF could mediate prelamin A-induced chromatin effects.
- Published
- 2010
29. Drugs affecting prelamin A processing: Effects on heterochromatin organization
- Author
-
Cristina Capanni, Spartaco Santi, Giuseppe Novelli, M. Riccio, Roland Foisner, Giovanna Lattanzi, Stefano Squarzoni, Marta Columbaro, Elisabetta Mattioli, M Rosaria D'Apice, Nadir M. Maraldi, Mattioli E, Columbaro M, Capanni C, Santi S, Maraldi NM, D'Apice MR, Novelli G, Riccio M, Squarzoni S, Foisner R, and Lattanzi G.
- Subjects
Adult ,Antimetabolites, Antineoplastic ,congenital, hereditary, and neonatal diseases and abnormalities ,Heterochromatin ,Protein Prenylation ,Biology ,Decitabine ,Methionine ,Prenylation ,Farnesyltranstransferase ,Humans ,prelamin A ,FTI-277 ,AFCMe ,5-azadeoxycytidine ,heterochromatin organization ,Enzyme Inhibitors ,Protein Precursors ,Heterochromatin organization ,Cells, Cultured ,Cell Nucleus ,Nuclear Lamina ,integumentary system ,Farnesyltransferase inhibitor ,Membrane Proteins ,Nuclear Proteins ,Cell Biology ,Fibroblasts ,Chromatin Assembly and Disassembly ,Lamin Type A ,Acetylcysteine ,Cell biology ,Chromatin ,DNA-Binding Proteins ,Biochemistry ,Azacitidine ,Nuclear lamina ,Protein farnesylation ,Cysteine - Abstract
Increasing interest in drugs acting on prelamin A has derived from the finding of prelamin A involvement in severe laminopathies. Amelioration of the nuclear morphology by inhibitors of prelamin A farnesylation has been widely reported in progeroid laminopathies. We investigated the effects on chromatin organization of two drugs inhibiting prelamin A processing by an ultrastructural and biochemical approach. The farnesyltransferase inhibitor FTI-277 and the non-peptidomimetic drug N-acetyl-S-farnesyl- l -cysteine methylester (AFCMe) were administered to cultured control human fibroblasts for 6 or 18 h. FTI-277 interferes with protein farnesylation causing accumulation of non-farnesylated prelamin A, while AFCMe impairs the last cleavage of the lamin A precursor and is expected to accumulate farnesylated prelamin A. FTI-277 caused redistribution of heterochromatin domains at the nuclear interior, while AFCMe caused loss of heterochromatin domains, increase of nuclear size and nuclear lamina thickening. At the biochemical level, heterochromatin-associated proteins and LAP2α were clustered at the nuclear interior following FTI-277 treatment, while they were unevenly distributed or absent in AFCMe-treated nuclei. The reported effects show that chromatin is an immediate target of FTI-277 and AFCMe and that dramatic remodeling of chromatin domains occurs following treatment with the drugs. These effects appear to depend, at least in part, on the accumulation of prelamin A forms, since impairment of prelamin A accumulation, here obtained by 5-azadeoxycytidine treatment, abolishes the chromatin effects. These results may be used to evaluate downstream effects of FTIs or other prelamin A inhibitors potentially useful for the therapy of laminopathies.
- Published
- 2008
30. SREBP1 interaction with prelamin A forms: a pathogenic mechanism for lipodystrophic laminopathies
- Author
-
Francesco A. Manzoli, Daria Camozzi, Cristina Capanni, Andrea Facchini, Giovanna Lattanzi, Nadir M. Maraldi, Maraldi NM, Capanni C, Lattanzi G, Camozzi D, Facchini A, and Manzoli FA.
- Subjects
Cancer Research ,Lipodystrophy ,Biology ,Models, Biological ,Mice ,3T3-L1 Cells ,Genetics ,Adipocytes ,Animals ,Humans ,Protein Precursors ,Protein Structure, Quaternary ,Molecular Biology ,Metabolic Syndrome ,Prenylation ,Mechanism (biology) ,Nuclear Proteins ,Cell Differentiation ,PRELAMIN A ,Lamin Type A ,Sterol regulatory element-binding protein ,Cell biology ,PPAR gamma ,Protein Transport ,Molecular Medicine ,Sterol Regulatory Element Binding Protein 1 - Published
- 2008
31. Laminopathies: a chromatin affair
- Author
-
Patrizia Sabatelli, Cristina Capanni, Nadir M. Maraldi, Giovanna Lattanzi, Elisabetta Mattioli, Francesco A. Manzoli, Stefano Squarzoni, Marta Columbaro, Maraldi NM, Lattanzi G, Capanni C, Columbaro M, Mattioli E, Sabatelli P, Squarzoni S, and Manzoli FA.
- Subjects
Genetics ,Cancer Research ,integumentary system ,Amino acid substitution ,Biology ,Chromatin ,Lamins ,Amino Acid Substitution ,Mutation ,Mutation (genetic algorithm) ,Animals ,Humans ,Molecular Medicine ,Molecular Biology ,Lamin - Abstract
In the last 5 years, an impressive series of genetic diseases (16 distinct diseased phenotypes have been so far identified), affecting metabolic and/or developmental processes, have been demonstrated to be caused by mutation of LMNA gene and collectively referred to as laminopathies. Most of these diseases are characterized by dystrophic/degenerative processes affecting different tissues and organs. Nuclear defects, consisting in heterochromatin focal or total loss and in nuclear lamina thickening or invagination, characterize the cells from laminopathic patients. Furthermore, accumulation of pre-lamin A has been demonstrated to occur, at least in a large group of laminopathies. These findings suggest a possible pathogenic mechanism for laminopathies. The cells bearing mutated pre-lamin A could not be able to maintain the chromatin organization required by differentiation programs, which represents an epigenetic marker of each cell lineage undergoing a differentiation process. These alterations have been demonstrated to be due to a lack of mutant lamin A to physiologically interact with heterochromatin-associated proteins, including HP1. The use of specific drugs that interfere with the maturation of lamin A allowed us to demonstrate that the accumulation of farnesylated pre-lamin A induces the appearance of nuclear phenotypes similar to those occurring in progeric syndromes. Furthermore, LMNA mutations found in several laminopathies reduce the transcriptional capability of the cells accumulating pre-lamin A. Therefore, the pathogenic mechanism of laminopathies appears to involve alterations of the chromatin organization and transcriptional capability required by differentiation programs, not necessarily during early embryogenesis, in which cells lack lamin A/C, but in adult cell populations capable of differentiating under specific stimuli. These cells, that onstitute the stem reservoir of several adult tissues, and that are typically represented by mesenchymal stromal cells, in the presence of mutant lamin A/C, and of accumulating prelamin A, present phenotypic alterations of the chromatin pattern and impairment of gene expression mechanisms. This could result in an accelerated cellular senescence, which could be characterized by the presence of progerin in progeric laminopathies, and of pre-lamin A in other laminopathies, in which not all tissues but specific tissues are involved. In fact, lamins and lamin-associated proteins, by constituting a platform for the interaction with transcription factors, may contribute to a fine modulation of gene expression programs, typical of each cell lineage.
- Published
- 2006
32. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy
- Author
-
Sandra Marmiroli, Andrea Ognibene, Patrizia Sabatelli, N.M. Maraldi, Marta Columbaro, Elisabetta Mattioli, Vittoria Cenni, Stefano Squarzoni, Cristina Capanni, Gisèle Bonne, Giovanna Lattanzi, Luciano Merlini, Cenni V, Sabatelli P, Mattioli E, Marmiroli S, Capanni C, Ognibene A, Squarzoni S, Maraldi NM, Bonne G, Columbaro M, Merlini L, and Lattanzi G.
- Subjects
medicine.medical_specialty ,congenital, hereditary, and neonatal diseases and abnormalities ,animal structures ,Muscle Fibers, Skeletal ,Emerin ,LMNA ,Biology ,Cell Line ,Myoblasts ,HUTCHINSON-GILFORD PROGERIA ,Mice ,NUCLEAR-ENVELOPE PROTEINS ,Internal medicine ,Genetics ,medicine ,Animals ,Humans ,Insulin ,Phosphorylation ,Muscular dystrophy ,Emery–Dreifuss muscular dystrophy ,Genetics (clinical) ,integumentary system ,Skeletal muscle ,Cell Differentiation ,DILATED CARDIOMYOPATHY ,Lamin Type A ,medicine.disease ,Muscular Dystrophy, Emery-Dreifuss ,Cell biology ,Endocrinology ,medicine.anatomical_structure ,Muscular Dystrophies, Limb-Girdle ,PARTIAL LIPODYSTROPHY ,embryonic structures ,Original Article ,Protein Processing, Post-Translational ,Lamin ,Signal Transduction ,Limb-girdle muscular dystrophy - Abstract
Background: Skeletal muscle disorders associated with mutations of lamin A/C gene include autosomal Emery–Dreifuss muscular dystrophy and limb girdle muscular dystrophy 1B. The pathogenic mechanism underlying these diseases is unknown. Recent data suggest an impairment of signalling mechanisms as a possible cause of muscle malfunction. A molecular complex in muscle cells formed by lamin A/C, emerin, and nuclear actin has been identified. The stability of this protein complex appears to be related to phosphorylation mechanisms. Objective: To analyse lamin A/C phosphorylation in control and laminopathic muscle cells. Methods: Lamin A/C N-terminal phosphorylation was determined in cultured mouse myoblasts using a specific antibody. Insulin treatment of serum starved myoblast cultures was carried out to evaluate involvement of insulin signalling in the phosphorylation pathway. Screening of four Emery–Dreifuss and one limb girdle muscular dystrophy 1B cases was undertaken to investigate lamin A/C phosphorylation in both cultured myoblasts and mature muscle fibres. Results: Phosphorylation of lamin A was observed during myoblast differentiation or proliferation, along with reduced lamin A/C phosphorylation in quiescent myoblasts. Lamin A N-terminus phosphorylation was induced by an insulin stimulus, which conversely did not affect lamin C phosphorylation. Lamin A/C was also hyperphosphorylated in mature muscle, mostly in regenerating fibres. Lamin A/C phosphorylation was strikingly reduced in laminopathic myoblasts and muscle fibres, while it was preserved in interstitial fibroblasts. Conclusions: Altered lamin A/C interplay with a muscle specific phosphorylation partner might be involved in the pathogenic mechanism of Emery–Dreifuss muscular dystrophy and limb girdle muscular dystrophy 1B.
- Published
- 2005
33. Gold(I)-Catalyzed Rautenstrauch/Hetero-Diels-Alder/Retro-aza-Michael Cascade Reaction for the Synthesis of α-Hydrazineyl-2-cyclopentenones.
- Author
-
Scarpi D, Capanni C, Visi S, Faggi C, and Occhiato EG
- Abstract
A one-pot synthesis of ring-fused, α-hydrazineyl-2-cyclopentenone derivatives is achieved by a gold(I)-catalyzed Rautenstrauch/hetero Diels-Alder/ring opening tandem reaction of suitable propargyl esters. By mixing the latter with a dialkylazodicarboxylate in the presence of a gold(I) catalyst, the 1,2-acyloxy migration/cyclization process (Rautenstrauch reaction) leads to cyclopentadienyl ester intermediates which are trapped by the heterodienophile present in situ. This provides strained intermediates which spontaneously undergo highly regioselective ring opening by a retro aza-Michael reaction promoted by the gold(I) catalyst, eventually yielding the target compounds. Six- and seven-membered ring-fused cyclopentenones bearing a pendant α-hydrazineyl moiety can be obtained in moderate to excellent yield (50-98%) by this approach, with a minimal erosion of the initial optical purity when using enantioenriched substrates.
- Published
- 2024
- Full Text
- View/download PDF
34. The NFATc1/P2X7 receptor relationship in human intervertebral disc cells.
- Author
-
Notarangelo MP, Penolazzi L, Lambertini E, Falzoni S, De Bonis P, Capanni C, Di Virgilio F, and Piva R
- Abstract
A comprehensive understanding of the molecules that play key roles in the physiological and pathological homeostasis of the human intervertebral disc (IVD) remains challenging, as does the development of new therapeutic treatments. We recently found a positive correlation between IVD degeneration (IDD) and P2X7 receptor (P2X7R) expression increases both in the cytoplasm and in the nucleus. Using immunocytochemistry, reverse transcription PCR (RT-PCR), overexpression, and chromatin immunoprecipitation, we found that NFATc1 and hypoxia-inducible factor-1α (HIF-1α) are critical regulators of P2X7R. Both transcription factors are recruited at the promoter of the P2RX7 gene and involved in its positive and negative regulation, respectively. Furthermore, using the proximity ligation assay, we revealed that P2X7R and NFATc1 form a molecular complex and that P2X7R is closely associated with lamin A/C, a major component of the nuclear lamina. Collectively, our study identifies, for the first time, P2X7R and NFATc1 as markers of IVD degeneration and demonstrates that both NFATc1 and lamin A/C are interaction partners of P2X7R., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Notarangelo, Penolazzi, Lambertini, Falzoni, De Bonis, Capanni, Di Virgilio and Piva.)
- Published
- 2024
- Full Text
- View/download PDF
35. Altered Mitochondrial Dynamic in Lymphoblasts and Fibroblasts Mutated for FANCA-A Gene: The Central Role of DRP1.
- Author
-
Bertola N, Bruno S, Capanni C, Columbaro M, Mazzarello AN, Corsolini F, Regis S, Degan P, Cappelli E, and Ravera S
- Subjects
- Humans, Fanconi Anemia Complementation Group A Protein genetics, Fanconi Anemia Complementation Group A Protein metabolism, Fibroblasts metabolism, Mitochondria metabolism, Proteins metabolism, Dynamins metabolism, Fanconi Anemia metabolism, Mitochondrial Dynamics genetics
- Abstract
Fanconi anemia (FA) is a rare genetic disorder characterized by bone marrow failure and aplastic anemia. So far, 23 genes are involved in this pathology, and their mutations lead to a defect in DNA repair. In recent years, it has been observed that FA cells also display mitochondrial metabolism defects, causing an accumulation of intracellular lipids and oxidative damage. However, the molecular mechanisms involved in the metabolic alterations have not yet been elucidated. In this work, by using lymphoblasts and fibroblasts mutated for the FANC-A gene, oxidative phosphorylation (OxPhos) and mitochondria dynamics markers expression was analyzed. Results show that the metabolic defect does not depend on an altered expression of the proteins involved in OxPhos. However, FA cells are characterized by increased uncoupling protein UCP2 expression. FANC-A mutation is also associated with DRP1 overexpression that causes an imbalance in the mitochondrial dynamic toward fission and lower expression of Parkin and Beclin1. Treatment with P110, a specific inhibitor of DRP1, shows a partial mitochondrial function recovery and the decrement of DRP1 and UCP2 expression, suggesting a pivotal role of the mitochondrial dynamics in the etiopathology of Fanconi anemia.
- Published
- 2023
- Full Text
- View/download PDF
36. The role of prelamin A post-translational maturation in stress response and 53BP1 recruitment.
- Author
-
Capanni C, Schena E, Di Giampietro ML, Montecucco A, Mattioli E, and Lattanzi G
- Abstract
Lamin A is a main constituent of the nuclear lamina and contributes to nuclear shaping, mechano-signaling transduction and gene regulation, thus affecting major cellular processes such as cell cycle progression and entry into senescence, cellular differentiation and stress response. The role of lamin A in stress response is particularly intriguing, yet not fully elucidated, and involves prelamin A post-translational processing. Here, we propose prelamin A as the tool that allows lamin A plasticity during oxidative stress response and permits timely 53BP1 recruitment to DNA damage foci. We show that while PCNA ubiquitination, p21 decrease and H2AX phosphorylation occur soon after stress induction in the absence of prelamin A, accumulation of non-farnesylated prelamin A follows and triggers recruitment of 53BP1 to lamin A/C complexes. Then, the following prelamin A processing steps causing transient accumulation of farnesylated prelamin A and maturation to lamin A reduce lamin A affinity for 53BP1 and favor its release and localization to DNA damage sites. Consistent with these observations, accumulation of prelamin A forms in cells under basal conditions impairs histone H2AX phosphorylation, PCNA ubiquitination and p21 degradation, thus affecting the early stages of stress response. As a whole, our results are consistent with a physiological function of prelamin A modulation during stress response aimed at timely recruitment/release of 53BP1 and other molecules required for DNA damage repair. In this context, it becomes more obvious how farnesylated prelamin A accumulation to toxic levels alters timing of DNA damage signaling and 53BP1 recruitment, thus contributing to cellular senescence and accelerated organismal aging as observed in progeroid laminopathies., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Capanni, Schena, Di Giampietro, Montecucco, Mattioli and Lattanzi.)
- Published
- 2022
- Full Text
- View/download PDF
37. Combined alteration of lamin and nuclear morphology influences the localization of the tumor-associated factor AKTIP.
- Author
-
La Torre M, Merigliano C, Maccaroni K, Chojnowski A, Goh WI, Giubettini M, Vernì F, Capanni C, Rhodes D, Wright G, Burke B, Soddu S, Burla R, and Saggio I
- Subjects
- Adaptor Proteins, Signal Transducing genetics, Animals, Apoptosis Regulatory Proteins metabolism, Fibroblasts metabolism, HeLa Cells, Humans, Mice, Telomere metabolism, Lamin Type A genetics, Lamin Type A metabolism, Progeria genetics, Progeria metabolism, Progeria pathology
- Abstract
Background: Lamins, key nuclear lamina components, have been proposed as candidate risk biomarkers in different types of cancer but their accuracy is still debated. AKTIP is a telomeric protein with the property of being enriched at the nuclear lamina. AKTIP has similarity with the tumor susceptibility gene TSG101. AKTIP deficiency generates genome instability and, in p53
-/- mice, the reduction of the mouse counterpart of AKTIP induces the exacerbation of lymphomas. Here, we asked whether the distribution of AKTIP is altered in cancer cells and whether this is associated with alterations of lamins., Methods: We performed super-resolution imaging, quantification of lamin expression and nuclear morphology on HeLa, MCF7, and A549 tumor cells, and on non-transformed fibroblasts from healthy donor and HGPS (LMNA c.1824C > T p.Gly608Gly) and EDMD2 (LMNA c.775 T > G) patients. As proof of principle model combining a defined lamin alteration with a tumor cell setting, we produced HeLa cells exogenously expressing the HGPS lamin mutant progerin that alters nuclear morphology., Results: In HeLa cells, AKTIP locates at less than 0.5 µm from the nuclear rim and co-localizes with lamin A/C. As compared to HeLa, there is a reduced co-localization of AKTIP with lamin A/C in both MCF7 and A549. Additionally, MCF7 display lower amounts of AKTIP at the rim. The analyses in non-transformed fibroblasts show that AKTIP mislocalizes in HGPS cells but not in EDMD2. The integrated analysis of lamin expression, nuclear morphology, and AKTIP topology shows that positioning of AKTIP is influenced not only by lamin expression, but also by nuclear morphology. This conclusion is validated by progerin-expressing HeLa cells in which nuclei are morphologically altered and AKTIP is mislocalized., Conclusions: Our data show that the combined alteration of lamin and nuclear morphology influences the localization of the tumor-associated factor AKTIP. The results also point to the fact that lamin alterations per se are not predictive of AKTIP mislocalization, in both non-transformed and tumor cells. In more general terms, this study supports the thesis that a combined analytical approach should be preferred to predict lamin-associated changes in tumor cells. This paves the way of next translational evaluation to validate the use of this combined analytical approach as risk biomarker., (© 2022. The Author(s).)- Published
- 2022
- Full Text
- View/download PDF
38. Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma.
- Author
-
Chiarini F, Paganelli F, Balestra T, Capanni C, Fazio A, Manara MC, Landuzzi L, Petrini S, Evangelisti C, Lollini PL, Martelli AM, Lattanzi G, and Scotlandi K
- Subjects
- Humans, Lamin Type A genetics, Lamin Type A metabolism, Membrane Proteins metabolism, Microtubule-Associated Proteins metabolism, Nuclear Proteins genetics, Nuclear Proteins metabolism, Nuclear Envelope metabolism, Sarcoma, Ewing genetics, Sarcoma, Ewing metabolism
- Abstract
Lamin A, a main constituent of the nuclear lamina, is involved in mechanosignaling and cell migration through dynamic interactions with the LINC complex, formed by the nuclear envelope proteins SUN1, SUN2 and the nesprins. Here, we investigated lamin A role in Ewing Sarcoma (EWS), an aggressive bone tumor affecting children and young adults. In patients affected by EWS, we found a significant inverse correlation between LMNA gene expression and tumor aggressiveness. Accordingly, in experimental in vitro models, low lamin A expression correlated with enhanced cell migration and invasiveness and, in vivo, with an increased metastatic load. At the molecular level, this condition was linked to altered expression and anchorage of nuclear envelope proteins and increased nuclear retention of YAP/TAZ, a mechanosignaling effector. Conversely, overexpression of lamin A rescued LINC complex organization, thus reducing YAP/TAZ nuclear recruitment and preventing cell invasiveness. These effects were also obtained through modulation of lamin A maturation by a statin-based pharmacological treatment that further elicited a more differentiated phenotype in EWS cells. These results demonstrate that drugs inducing nuclear envelope remodeling could be exploited to improve therapeutic strategies for EWS., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
39. Morphological study of TNPO3 and SRSF1 interaction during myogenesis by combining confocal, structured illumination and electron microscopy analysis.
- Author
-
Costa R, Rodia MT, Zini N, Pegoraro V, Marozzo R, Capanni C, Angelini C, Lattanzi G, Santi S, and Cenacchi G
- Subjects
- Animals, Cell Line, Mice, Microscopy, Confocal, Microscopy, Electron, Cell Nucleus metabolism, Cell Nucleus ultrastructure, Cytoplasm metabolism, Cytoplasm ultrastructure, Muscle Development, Serine-Arginine Splicing Factors metabolism, beta Karyopherins metabolism
- Abstract
Transportin3 (TNPO3) shuttles the SR proteins from the cytoplasm to the nucleus. The SR family includes essential splicing factors, such as SRSF1, that influence alternative splicing, controlling protein diversity in muscle and satellite cell differentiation. Given the importance of alternative splicing in the myogenic process and in the maintenance of healthy muscle, alterations in the splicing mechanism might contribute to the development of muscle disorders. Combining confocal, structured illumination and electron microscopy, we investigated the expression of TNPO3 and SRSF1 during myogenesis, looking at nuclear and cytoplasmic compartments. We investigated TNPO3 and its interaction with SRSF1 and we observed that SRSF1 remained mainly localized in the nucleus, while TNPO3 decreased in the cytoplasm and was strongly clustered in the nuclei of differentiated myotubes. In conclusion, combining different imaging techniques led us to describe the behavior of TNPO3 and SRSF1 during myogenesis, showing that their dynamics follow the myogenic process and could influence the proteomic network necessary during myogenesis. The combination of different high-, super- and ultra-resolution imaging techniques led us to describe the behavior of TNPO3 and its interaction with SRSF1, looking at nuclear and cytoplasmic compartments. These observations represent a first step in understanding the role of TNPO3 and SRFSF1 in complex mechanisms, such as myogenesis.
- Published
- 2021
- Full Text
- View/download PDF
40. Ectopic Expression of Ankrd2 Affects Proliferation, Motility and Clonogenic Potential of Human Osteosarcoma Cells.
- Author
-
Piazzi M, Kojic S, Capanni C, Stamenkovic N, Bavelloni A, Marin O, Lattanzi G, Blalock W, and Cenni V
- Abstract
Ankrd2 is a protein known for being mainly expressed in muscle fibers, where it participates in the mechanical stress response. Since both myocytes and osteoblasts are mesenchymal-derived cells, we were interested in examining the role of Ankrd2 in the progression of osteosarcoma which features a mechano-stress component. Although having been identified in many tumor-derived cell lines and -tissues, no study has yet described nor hypothesized any involvement for this protein in osteosarcoma tumorigenesis. In this paper, we report that Ankrd2 is expressed in cell lines obtained from human osteosarcoma and demonstrate a contribution by this protein in the pathogenesis of this insidious disease. Ankrd2 involvement in osteosarcoma development was evaluated in clones of Saos2, U2OS, HOS and MG63 cells stably expressing Ankrd2, through the investigation of hallmark processes of cancer cells. Interestingly, we found that exogenous expression of Ankrd2 influenced cellular growth, migration and clonogenicity in a cell line-dependent manner, whereas it was able to improve the formation of 3D spheroids in three out of four cellular models and enhanced matrix metalloproteinase (MMP) activity in all tested cell lines. Conversely, downregulation of Ankrd2 expression remarkably reduced proliferation and clonogenic potential of parental cells. As a whole, our data present Ankrd2 as a novel player in osteosarcoma development, opening up new therapeutic perspectives.
- Published
- 2021
- Full Text
- View/download PDF
41. Interleukin-6 neutralization ameliorates symptoms in prematurely aged mice.
- Author
-
Squarzoni S, Schena E, Sabatelli P, Mattioli E, Capanni C, Cenni V, D'Apice MR, Andrenacci D, Sarli G, Pellegrino V, Festa A, Baruffaldi F, Storci G, Bonafè M, Barboni C, Sanapo M, Zaghini A, and Lattanzi G
- Subjects
- Aging, Animals, Humans, Mice, Progeria pathology, Interleukin-6 metabolism, Progeria genetics
- Abstract
Hutchinson-Gilford progeria syndrome (HGPS) causes premature aging in children, with adipose tissue, skin and bone deterioration, and cardiovascular impairment. In HGPS cells and mouse models, high levels of interleukin-6, an inflammatory cytokine linked to aging processes, have been detected. Here, we show that inhibition of interleukin-6 activity by tocilizumab, a neutralizing antibody raised against interleukin-6 receptors, counteracts progeroid features in both HGPS fibroblasts and Lmna
G609G / G609G progeroid mice. Tocilizumab treatment limits the accumulation of progerin, the toxic protein produced in HGPS cells, rescues nuclear envelope and chromatin abnormalities, and attenuates the hyperactivated DNA damage response. In vivo administration of tocilizumab reduces aortic lesions and adipose tissue dystrophy, delays the onset of lipodystrophy and kyphosis, avoids motor impairment, and preserves a good quality of life in progeroid mice. This work identifies tocilizumab as a valuable tool in HGPS therapy and, speculatively, in the treatment of a variety of aging-related disorders., (© 2021 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.)- Published
- 2021
- Full Text
- View/download PDF
42. Lamin A involvement in ageing processes.
- Author
-
Cenni V, Capanni C, Mattioli E, Schena E, Squarzoni S, Bacalini MG, Garagnani P, Salvioli S, Franceschi C, and Lattanzi G
- Subjects
- Humans, Lamin Type A genetics, MicroRNAs, Mutation, Nuclear Proteins, Progeria genetics, Protein Precursors genetics, Aging genetics
- Abstract
Lamin A, a main constituent of the nuclear lamina, is the major splicing product of the LMNA gene, which also encodes lamin C, lamin A delta 10 and lamin C2. Involvement of lamin A in the ageing process became clear after the discovery that a group of progeroid syndromes, currently referred to as progeroid laminopathies, are caused by mutations in LMNA gene. Progeroid laminopathies include Hutchinson-Gilford Progeria, Mandibuloacral Dysplasia, Atypical Progeria and atypical-Werner syndrome, disabling and life-threatening diseases with accelerated ageing, bone resorption, lipodystrophy, skin abnormalities and cardiovascular disorders. Defects in lamin A post-translational maturation occur in progeroid syndromes and accumulated prelamin A affects ageing-related processes, such as mTOR signaling, epigenetic modifications, stress response, inflammation, microRNA activation and mechanosignaling. In this review, we briefly describe the role of these pathways in physiological ageing and go in deep into lamin A-dependent mechanisms that accelerate the ageing process. Finally, we propose that lamin A acts as a sensor of cell intrinsic and environmental stress through transient prelamin A accumulation, which triggers stress response mechanisms. Exacerbation of lamin A sensor activity due to stably elevated prelamin A levels contributes to the onset of a permanent stress response condition, which triggers accelerated ageing., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
43. PCAF Involvement in Lamin A/C-HDAC2 Interplay during the Early Phase of Muscle Differentiation.
- Author
-
Santi S, Cenni V, Capanni C, Lattanzi G, and Mattioli E
- Subjects
- Animals, HEK293 Cells, Humans, Lamin Type A genetics, Mice, Models, Biological, Muscular Dystrophy, Emery-Dreifuss genetics, Muscular Dystrophy, Emery-Dreifuss pathology, Mutation genetics, Nuclear Lamina metabolism, Phenotype, Protein Binding, Cell Differentiation, Histone Deacetylase 2 metabolism, Lamin Type A metabolism, Muscles cytology, p300-CBP Transcription Factors metabolism
- Abstract
Lamin A/C has been implicated in the epigenetic regulation of muscle gene expression through dynamic interaction with chromatin domains and epigenetic enzymes. We previously showed that lamin A/C interacts with histone deacetylase 2 (HDAC2). In this study, we deepened the relevance and regulation of lamin A/C-HDAC2 interaction in human muscle cells. We present evidence that HDAC2 binding to lamina A/C is related to HDAC2 acetylation on lysine 75 and expression of p300-CBP associated factor (PCAF), an acetyltransferase known to acetylate HDAC2. Our findings show that lamin A and farnesylated prelamin A promote PCAF recruitment to the nuclear lamina and lamin A/C binding in human myoblasts committed to myogenic differentiation, while protein interaction is decreased in differentiating myotubes. Interestingly, PCAF translocation to the nuclear envelope, as well as lamin A/C-PCAF interaction, are reduced by transient expression of lamin A mutated forms causing Emery Dreifuss muscular dystrophy. Consistent with this observation, lamin A/C interaction with both PCAF and HDAC2 is significantly reduced in Emery-Dreifuss muscular dystrophy myoblasts. Overall, these results support the view that, by recruiting PCAF and HDAC2 in a molecular platform, lamin A/C might contribute to regulate their epigenetic activity required in the early phase of muscle differentiation.
- Published
- 2020
- Full Text
- View/download PDF
44. Emerin Phosphorylation during the Early Phase of the Oxidative Stress Response Influences Emerin-BAF Interaction and BAF Nuclear Localization.
- Author
-
Cenni V, Squarzoni S, Loi M, Mattioli E, Lattanzi G, and Capanni C
- Subjects
- DNA Damage, DNA-Binding Proteins metabolism, HEK293 Cells, HeLa Cells, Humans, Lamin Type A deficiency, Lamin Type A metabolism, Molecular Weight, Muscular Dystrophy, Emery-Dreifuss pathology, Phosphorylation, Protein Binding, Protein Transport, Reactive Oxygen Species metabolism, Cell Nucleus metabolism, Membrane Proteins metabolism, Nuclear Proteins metabolism, Oxidative Stress
- Abstract
Reactive Oxygen Species (ROS) are reactive molecules required for the maintenance of physiological functions. Oxidative stress arises when ROS production exceeds the cellular ability to eliminate such molecules. In this study, we showed that oxidative stress induces post-translational modification of the inner nuclear membrane protein emerin. In particular, emerin is phosphorylated at the early stages of the oxidative stress response, while protein phosphorylation is abolished upon recovery from stress. A finely tuned balance between emerin phosphorylation and O -GlcNAcylation seems to govern this dynamic and modulates emerin-BAF interaction and BAF nucleoplasmic localization during the oxidative stress response. Interestingly, emerin post-translational modifications, similar to those observed during the stress response, are detected in cells bearing LMNA gene mutations and are characterized by a free radical generating environment. On the other hand, under oxidative stress conditions, a delay in DNA damage repair and cell cycle progression is found in cells from Emery-Dreifuss Muscular Dystrophy type 1, which do not express emerin. These results suggest a role of the emerin-BAF protein platform in the DNA damage response aimed at counteracting the detrimental effects of elevated levels of ROS.
- Published
- 2020
- Full Text
- View/download PDF
45. Long term breeding of the Lmna G609G progeric mouse: Characterization of homozygous and heterozygous models.
- Author
-
Zaghini A, Sarli G, Barboni C, Sanapo M, Pellegrino V, Diana A, Linta N, Rambaldi J, D'Apice MR, Murdocca M, Baleani M, Baruffaldi F, Fognani R, Mecca R, Festa A, Papparella S, Paciello O, Prisco F, Capanni C, Loi M, Schena E, Lattanzi G, and Squarzoni S
- Subjects
- Animals, Disease Models, Animal, Membrane Proteins genetics, Mice, Mutation, Phenotype, Breeding, Heterozygote, Homozygote, Lamin Type A genetics, Progeria genetics
- Abstract
The transgenic Lmna
G609G progeric mouse represents an outstanding animal model for studying the human Hutchinson-Gilford Progeria Syndrome (HGPS) caused by a mutation in the LMNA gene, coding for the nuclear envelope protein Lamin A/C, and, as an important, more general scope, for studying the complex process governing physiological aging in humans. Here we give a comprehensive description of the peculiarities related to the breeding of LmnaG609G mice over a prolonged period of time, and of many features observed in a large colony for a 2-years period. We describe the breeding and housing conditions underlining the possible interference of the genetic background on the phenotype expression. This information represents a useful tool when planning and interpreting studies on the LmnaG609G mouse model, complementing any specific data already reported in the literature about this model since its production. It is also particularly relevant for the heterozygous mouse, which mirrors the genotype of the human pathology however requires an extended time to manifest symptoms and to be carefully studied., (Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
46. Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning.
- Author
-
Pellegrini C, Columbaro M, Schena E, Prencipe S, Andrenacci D, Iozzo P, Angela Guzzardi M, Capanni C, Mattioli E, Loi M, Araujo-Vilar D, Squarzoni S, Cinti S, Morselli P, Giorgetti A, Zanotti L, Gambineri A, and Lattanzi G
- Subjects
- Adipocytes physiology, Adipogenesis physiology, Adipose Tissue, Brown metabolism, Adipose Tissue, Brown physiology, Adult, Cells, Cultured, Female, Humans, Lipodystrophy, Familial Partial metabolism, Lipodystrophy, Familial Partial physiopathology, Middle Aged, Young Adult, Adipocytes pathology, Adipocytes, Brown physiology, Autophagy physiology, Cell Differentiation, Cell Transdifferentiation physiology, Lipodystrophy, Familial Partial pathology
- Abstract
Type-2 Familial Partial Lipodystrophy is caused by LMNA mutations. Patients gradually lose subcutaneous fat from the limbs, while they accumulate adipose tissue in the face and neck. Several studies have demonstrated that autophagy is involved in the regulation of adipocyte differentiation and the maintenance of the balance between white and brown adipose tissue. We identified deregulation of autophagy in laminopathic preadipocytes before induction of differentiation. Moreover, in differentiating white adipocyte precursors, we observed impairment of large lipid droplet formation, altered regulation of adipose tissue genes, and expression of the brown adipose tissue marker UCP1. Conversely, in lipodystrophic brown adipocyte precursors induced to differentiate, we noticed activation of autophagy, formation of enlarged lipid droplets typical of white adipocytes, and dysregulation of brown adipose tissue genes. In agreement with these in vitro results indicating conversion of FPLD2 brown preadipocytes toward the white lineage, adipose tissue from FPLD2 patient neck, an area of brown adipogenesis, showed a white phenotype reminiscent of its brown origin. Moreover, in vivo morpho-functional evaluation of fat depots in the neck area of three FPLD2 patients by PET/CT analysis with cold stimulation showed the absence of brown adipose tissue activity. These findings highlight a new pathogenetic mechanism leading to improper fat distribution in lamin A-linked lipodystrophies and show that both impaired white adipocyte turnover and failure of adipose tissue browning contribute to disease.
- Published
- 2019
- Full Text
- View/download PDF
47. Ankrd2 in Mechanotransduction and Oxidative Stress Response in Skeletal Muscle: New Cues for the Pathogenesis of Muscular Laminopathies.
- Author
-
Cenni V, Kojic S, Capanni C, Faulkner G, and Lattanzi G
- Subjects
- Humans, Lamin Type A metabolism, Mechanotransduction, Cellular, Muscle Proteins chemistry, Muscular Dystrophy, Emery-Dreifuss metabolism, Myocardium metabolism, Nuclear Proteins chemistry, Protein Isoforms chemistry, Protein Isoforms metabolism, Reactive Oxygen Species metabolism, Repressor Proteins chemistry, Muscle Proteins metabolism, Muscle, Skeletal metabolism, Muscular Dystrophy, Emery-Dreifuss pathology, Nuclear Proteins metabolism, Oxidative Stress, Repressor Proteins metabolism
- Abstract
Ankrd2 (ankyrin repeats containing domain 2) or Arpp (ankyrin repeat, PEST sequence, and proline-rich region) is a member of the muscle ankyrin repeat protein family. Ankrd2 is mostly expressed in skeletal muscle, where it plays an intriguing role in the transcriptional response to stress induced by mechanical stimulation as well as by cellular reactive oxygen species. Our studies in myoblasts from Emery-Dreifuss muscular dystrophy 2, a LMNA -linked disease affecting skeletal and cardiac muscles, demonstrated that Ankrd2 is a lamin A-binding protein and that mutated lamins found in Emery-Dreifuss muscular dystrophy change the dynamics of Ankrd2 nuclear import, thus affecting oxidative stress response. In this review, besides describing the latest advances related to Ankrd2 studies, including novel discoveries on Ankrd2 isoform-specific functions, we report the main findings on the relationship of Ankrd2 with A-type lamins and discuss known and potential mechanisms involving defective Ankrd2-lamin A interplay in the pathogenesis of muscular laminopathies., Competing Interests: The authors declare no conflict of interest.
- Published
- 2019
- Full Text
- View/download PDF
48. Statins and Histone Deacetylase Inhibitors Affect Lamin A/C - Histone Deacetylase 2 Interaction in Human Cells.
- Author
-
Mattioli E, Andrenacci D, Mai A, Valente S, Robijns J, De Vos WH, Capanni C, and Lattanzi G
- Abstract
We recently identified lamin A/C as a docking molecule for human histone deacetylase 2 (HDAC2) and showed involvement of HDAC2-lamin A/C complexes in the DNA damage response. We further showed that lamin A/C-HDAC2 interaction is altered in Hutchinson-Gilford Progeria syndrome and other progeroid laminopathies. Here, we show that both inhibitors of lamin A maturation and small molecules inhibiting HDAC activity affect lamin A/C interaction with HDAC2. While statins, which inhibit prelamin A processing, reduce protein interaction, HDAC inhibitors strengthen protein binding. Moreover, treatment with HDAC inhibitors restored the enfeebled lamin A/C-HDAC2 interaction observed in HGPS cells. Based on these results, we propose that prelamin A levels as well as HDAC2 activation status might influence the extent of HDAC2 recruitment to the lamin A/C-containing platform and contribute to modulate HDAC2 activity. Our study links prelamin A processing to HDAC2 regulation and provides new insights into the effect of statins and histone deacetylase inhibitors on lamin A/C functionality in normal and progeroid cells.
- Published
- 2019
- Full Text
- View/download PDF
49. Emery-Dreifuss Muscular Dystrophy-Associated Mutant Forms of Lamin A Recruit the Stress Responsive Protein Ankrd2 into the Nucleus, Affecting the Cellular Response to Oxidative Stress.
- Author
-
Angori S, Capanni C, Faulkner G, Bean C, Boriani G, Lattanzi G, and Cenni V
- Subjects
- Cell Survival drug effects, Cells, Cultured, HEK293 Cells, Humans, Hydrogen Peroxide toxicity, Immunoprecipitation, Lamin Type A chemistry, Lamin Type A genetics, Microscopy, Fluorescence, Muscle Proteins chemistry, Muscle Proteins genetics, Muscle, Skeletal cytology, Muscle, Skeletal drug effects, Muscle, Skeletal metabolism, Muscular Dystrophy, Emery-Dreifuss genetics, Muscular Dystrophy, Emery-Dreifuss metabolism, Myoblasts cytology, Myoblasts drug effects, Myoblasts metabolism, Nuclear Proteins chemistry, Nuclear Proteins genetics, Plasmids genetics, Plasmids metabolism, Protein Binding, Protein Prenylation drug effects, Reactive Oxygen Species metabolism, Repressor Proteins chemistry, Repressor Proteins genetics, Cell Nucleus metabolism, Lamin Type A metabolism, Muscle Proteins metabolism, Muscular Dystrophy, Emery-Dreifuss pathology, Nuclear Proteins metabolism, Oxidative Stress drug effects, Repressor Proteins metabolism
- Abstract
Background: Ankrd2 is a stress responsive protein mainly expressed in muscle cells. Upon the application of oxidative stress, Ankrd2 translocates into the nucleus where it regulates the activity of genes involved in cellular response to stress. Emery-Dreifuss Muscular Dystrophy 2 (EDMD2) is a muscular disorder caused by mutations of the gene encoding lamin A, LMNA. As well as many phenotypic abnormalities, EDMD2 muscle cells also feature a permanent basal stress state, the underlying molecular mechanisms of which are currently unclear., Methods: Experiments were performed in EDMD2-lamin A overexpressing cell lines and EDMD2-affected human myotubes. Oxidative stress was produced by H2O2 treatment. Co-immunoprecipitation, cellular subfractionation and immunofluorescence analysis were used to validate the relation between Ankrd2 and forms of lamin A; cellular sensibility to stress was monitored by the analysis of Reactive Oxygen Species (ROS) release and cell viability., Results: Our data demonstrate that oxidative stress induces the formation of a complex between Ankrd2 and lamin A. However, EDMD2-lamin A mutants were able to bind and mislocalize Ankrd2 in the nucleus even under basal conditions. Nonetheless, cells co-expressing Ankrd2 and EDMD2-lamin A mutants were more sensitive to oxidative stress than the Ankrd2-wild type lamin A counterpart., Conclusions: For the first time, we present evidence that in muscle fibers from patients affected by EDMD2, Ankrd2 has an unusual nuclear localization. By introducing a plausible mechanism ruling this accumulation, our data hint at a novel function of Ankrd2 in the pathogenesis of EDMD2-affected cells., (© 2017 The Author(s). Published by S. Karger AG, Basel.)
- Published
- 2017
- Full Text
- View/download PDF
50. Detection of mesenchymal stem cells senescence by prelamin A accumulation at the nuclear level.
- Author
-
Bellotti C, Capanni C, Lattanzi G, Donati D, Lucarelli E, and Duchi S
- Abstract
Background: Human mesenchymal stem cells (MSC), during in vitro expansion, undergo a progressive loss of proliferative potential that leads to the senescent state, associated with a reduction of their "medicinal" properties. This may hampers their efficacy in the treatment of injured tissues. Quality controls on MSC-based cell therapy products should include an assessment of the senescent state. However, a reliable and specific marker is still missing. From studies on lamin-associated disorders, has emerged the correlation between defective lamin A maturation and cellular senescence., Findings: Primary cultured hMSC lines (n = 3), were analyzed by immunostaining at different life-span stages for the accumulation of prelamin A, along with other markers of cellular senescence. During culture, cells at the last stage of their life span displayed evident signs of senescence consistent with the positivity of SA-β-gal staining. We also observed a significant increase of prelamin A positive cells. Furthermore, we verified that the cells marked by prelamin A were also positive for p21(Waf1) while negative for Ki67., Conclusions: Overall data support that the detection of prelamin A identifies senescent MSC, providing an easy and reliable tool to be use alone or in combination with known senescence markers to screen MSC before their use in clinical applications.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.